Australia now pegs its sun advice to skin tone, season and location
The DNA damage behind skin cancer has a settled mechanism and a dose-response. The benefits attributed to sunlight rest on observational studies that vitamin D supplement trials have not confirmed, and guidance is beginning to split.
Reality
- Evidence60
- Adoption30
- Hype gap+18
- Incentives35
- Confidence55
A structure dropped from Gray's Anatomy turns up with tubes and secreted proteins in adult mice
Duke researchers imaged whole mouse ovaries and report in eLife that the rete ovarii keeps three distinct regions into adulthood, with cell-secreted proteins in its tubes and nerve fibers connected to one of them.
Reality
- Evidence55
- Adoption
- Not scored
- Hype gap+18
- Incentives
- Not scored
- Confidence52
Risk this large has been hard to measure because the variant is so rare, and the estimate exists because a consumer genetics cohort held 641 carriers when two major biobanks held 21. A CT screening trial is now running.
Reality
- Evidence70
- Adoption22
- Hype gap+8
- Incentives45
- Confidence66
Proteogenomics of 112 young glioma tumors finds a biological break near age 26
Mount Sinai and CPTAC collaborators measured DNA, RNA, proteins and protein modifications in tumors from patients aged 83 days to 40 years. Molecular profiles and survival split adolescents and young adults into two groups.
Reality
- Evidence63
- Adoption
- Not scored
- Hype gap+12
- Incentives65
- Confidence48
WashU team ties a widening biological age gap to cancer before 55
A Nature Medicine study from Washington University reports that more recent generations look biologically older than earlier ones did at the same age, and that a larger gap goes with higher risk of early-onset cancer.
Reality
- Evidence52
- Adoption
- Not scored
- Hype gap+18
- Incentives60
- Confidence55
Blocking SET left glioblastoma cells more vulnerable to radiation in preclinical models
Ohio State reports that glioblastoma suppresses the enzyme PP2A using three of its own proteins, and that knocking those down in lab and animal models killed more cells and left the survivors easier to irradiate. No patients have been treated.
Reality
- Evidence42
- Adoption
- Not scored
- Hype gap+22
- Incentives65
- Confidence52
Financial planning tied to 56% lower death rate among high-risk cancer patients, separate program aids 3,500 more
The National Cancer Institute treats financial toxicity as a clinical variable. The studies advisors cite claim it moves survival. That claim is what turns the few weeks before treatment starts into billable ground.
Reality
- Evidence30
- Adoption26
- Hype gap+34
- Incentives74
- Confidence38
HPV's other cancer: a tripling in men's throats, and no test that finds it
Cervical cancer is falling where vaccination took hold. HPV throat and mouth cancers tripled in US data to 2004 and again in Danish data to 2017, mostly in men, with no screening test.
Reality
- Evidence68
- Adoption44
- Hype gap−8
- Incentives
- Not scored
- Confidence62
Ribosomes run nearly twice as fast on ac4C mRNA, putting the platform default in play
Johns Hopkins and NIH researchers report faster, cleaner translation from an alternative mRNA modification than from the chemistry used in COVID-19 mRNA vaccines. Dose economics is the open question.
Reality
- Evidence52
- Adoption
- Not scored
- Hype gap+32
- Incentives62
- Confidence44